|
Chair: Dr Derick Todd, Prof Tim Betts |
|
Liverpool, UK, Oxford, UK |
|
|
What QoL reduction related to AF is necessary to make ablation a worthwhile procedure and how do we measure it? |
Dr Kim Rajappan |
Oxford, UK |
|
|
What should we do in addition to PVI for 1st time persistent AF – the posterior box or something else? |
Prof Dhiraj Gupta |
Liverpool, UK |
|
|
How to judge when can we stop anticoagulants in post AF ablation when CHADSVASc>1 |
Prof A. John Camm |
London, UK |
|
|
Should LAAO isolation & occlusion be part of treatment for persistent AF? |
Dr Dhanunjaya Lakkireddy |
Kansas, US |
|
|
AF ablation to treat heart failure. Therapy or futility? |
Prof Pier Lambiase |
London, UK |
|
|
Do better lesions mean better outcomes? Power, force or electroporation – what is the answer? |
Prof Helmut Puererfellner |
Linz, AT |
|
|
How to define AF substrate: Voltage, velocities or late LGE and does it help guide ablation? |
Prof Andre Ng |
Leicester, UK |
|
|
How to map atrial fibrillation and identify targets for ablation |
Dr Tom Wong |
London, UK |
|
|
Chair: Dr Shouvik Haldar |
|
London, UK |
|
|
AF ablation as first line therapy - Debate (Pro) |
Dr Guy Haywood |
Plymouth, UK |
|
|
AF ablation as first line therapy - Debate (Con) |
Dr Hugh Calkins |
Baltimore, US |
|
|
Chair: Prof Andre Ng |
|
Leicester, UK |
|
|
Cryo ablation should be the index ablation for all (Pro) |
Dr Jason Andrade |
Vancouver, CA |
|
|
Cryo ablation should be the index ablation for all (Con) |
Dr Damian Redfearn |
Kingston, CA |
|